Multiple sclerosis (MS) for the urologist: What should urologists know about MS?

Area of Science:

• Neurology
• Immunology
• Neuroinflammation

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) primarily affecting young adults.
• Characterized by a wide range of clinical symptoms, MS has a female predominance and can present with varying disease courses.
• The exact cause of MS remains unknown, but it is hypothesized to involve autoimmune attacks on myelin and axons, influenced by genetic and environmental factors.

Purpose of the Study:

• To review current knowledge on multiple sclerosis (MS).
• To emphasize the importance of understanding MS for urologists in integrating practice recommendations.

Main Methods:

• Diagnosis relies on a combination of clinical, radiological (MRI), and laboratory investigations.
• Treatment strategies include long-term immunomodulatory management and short-term symptomatic control.
• Evaluation of first-line (Interferon, Glatiramer acetate) and second-line therapies with differing efficacy and safety profiles.

Main Results:

• MS therapies aim to modify disease progression and manage symptoms to improve quality of life (QoL).
• Disease-modifying medications offer opportunities to alter the disease's course and enhance long-term QoL.
• First-line treatments have limited effects and fair safety, while newer second-line therapies offer improved efficacy but carry higher risks.

Conclusions:

• This review provides a summary of current understanding regarding multiple sclerosis.
• Urologists require enhanced knowledge for better integration of clinical practice guidelines related to MS management.